N-Terminal Pro-B-Type Natriuretic Peptide, Vascular Disease Risk, and Cholesterol Reduction Among 20,536 Patients in the MRC/BHF Heart Protection Study
J Am Coll Cardiol Heart Protection Study Collaborative Group,*
49: 311
Online Appendix
Acknowledgement and Writing Group
Files in this Data Supplement:
|